Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 16:9:1061586.
doi: 10.3389/fcvm.2022.1061586. eCollection 2022.

Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock

Affiliations
Case Reports

Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock

Peng Ding et al. Front Cardiovasc Med. .

Abstract

Background: Kounis syndrome is a hypersensitive coronary artery disease caused by the body's exposure to allergens, which is induced by various drugs and environmental factors. This entity has been described primarily in isolated case reports and case series. We report a case of type III Kounis syndrome caused by cefoperazone-sulbactam.

Case presentation: A 79-year-old man who received an infusion of cefoperazone-sulbactam in Respiratory Department of our hospital for recurrent infections. 28 minutes later, he developed skin flushing of the trunk and extremities, soon followed by loss of consciousness and shock. With antianaphylaxis, pressor therapy, and fluid rehydration, the patient was admitted to the ICU for treatment. During which, he experienced recurrent ventricular fibrillation and a progressive increase in troponin I levels. The ECG of the patient showed that the ST segment elevation of lead II, III, avF, and V3R-V5R was 0.10-0.20 MV. An urgent coronary angiography showed an in-stent thrombosis in the middle part of the right coronary artery, occlusion of the distal flow with TIMI grade 0. The diagnosis was type III Kounis syndrome with cardiogenic shock. Despite aggressive treatment, the patient died on day 7 after ICU admission.

Conclusion: Kunis syndrome is a life-threatening disease, and therefore allergic reactions in patients with a history of cephalosporin allergy and coronary stent implantation should be considered and treated promptly.

Keywords: Kounis syndrome; allergy; cardiogenic shock; case report; cefoperazone-sulbactam; intra-stent thrombosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The bedside cardiac ultrasound suggested poor cardiac contractile function and left ventricular ejection fraction only 25%.
Figure 2
Figure 2
The after admission to ICU, 18-lead electrocardiogram (ECG) showed that the ST segment of lead I, aVL, V2–V6 depression 0.1–0.3 mV, and the ST segment of lead II, III, avF, V3R-V5R elevation 0.10–0.20 mV.
Figure 3
Figure 3
(A) Right coronary angiography 1 months ago. Results of coronary angiography. (B) Right coronary artery: stent shadow was seen from the proximal segment to the middle segment, complete occlusion in the middle stent, myocardial infarction (TIMI) blood flow grade 0. (C) Coronary angiography after balloon dilation and thrombus aspiration showed no stenosis, and TIMI flow was grade 3.
Figure 4
Figure 4
Postoperative electrocardiogram showing ST segment elevation 0.05–0.1 MV in lead III and avF.

Similar articles

Cited by

References

    1. Kounis NG, Koniari I, Velissaris D, Tzanis G, Hahalis G. Kounis Syndrome—not a single-organ arterial disorder but a multisystem and multidisciplinary disease. Balkan Med J. (2019) 36:212–21. 10.4274/balkanmedj.galenos.2019.2019.5.62 - DOI - PMC - PubMed
    1. Fang W, Song L, Deng Z, Sun W, Li Z, Wang C. Analysis of clinical features of Kounis syndrome induced by cephalosporin. Front Cardiovasc Med. (2022) 9:885438. 10.3389/fcvm.2022.885438 - DOI - PMC - PubMed
    1. Adachi H, Ihara M, Nojima Y, Kurimoto T, Nanto S. Kounis syndrome caused by anaphylaxis without skin manifestations after cefazolin administration. J Allergy Clin Immunol Pract. (2019) 7:317–9. 10.1016/j.jaip.2018.05.030 - DOI - PubMed
    1. Absmaier M, Biedermann T, Brockow K. Allergic myocardial infarction (Kounis syndrome) after cefuroxime with side-chain cross-reactivity. J Allergy Clin Immunol Pract. (2018) 6:1781–3.e1. 10.1016/j.jaip.2018.01.033 - DOI - PubMed
    1. Pradhan S, Christ M, Trappe HJ. Kounis syndrome induced by amoxicillin following vasospastic coronary event in a 22-year-old patient: a case report. Cardiovasc Diagn Ther. (2018) 8:180–5. 10.21037/cdt.2018.03.07 - DOI - PMC - PubMed

Publication types

LinkOut - more resources